Cargando…

Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients

Analysis of circulating tumor DNA (ctDNA) can be used to characterize and monitor cancers. Recently, non-invasive prenatal testing (NIPT) as a new next-generation sequencing (NGS)-based approach has been applied for detecting ctDNA. This study aimed to investigate the copy number variations (CNVs) u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharbatoghli, Mina, Fattahi, Fahimeh, Aboulkheyr Es, Hamidreza, Akbari, Arvand, Akhavan, Setareh, Ebrahimi, Marzieh, Asadi-Lari, Mohsen, Totonchi, Mehdi, Madjd, Zahra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355329/ https://www.ncbi.nlm.nih.gov/pubmed/35938032 http://dx.doi.org/10.3389/fgene.2022.938985

Ejemplares similares

Prediction of the treatment response in ovarian cancer: a ctDNA approach
por: Sharbatoghli, Mina, et al.
Publicado: (2020)

The Association Between Higher Expression of Talin-1 and the Reduced Survival Rate in Ovarian Serous Carcinoma Patients
por: Sharbatoghli, Mina, et al.
Publicado: (2023)

Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma
por: Sharbatoghli, Mina, et al.
Publicado: (2022)

Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
por: Es, Hamidreza Aboulkheyr, et al.
Publicado: (2021)

Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review
por: Vafaei, Somayeh, et al.
Publicado: (2019)

Imaging single DNA molecules for high precision NIPT
por: Dahl, Fredrik, et al.
Publicado: (2018)

Inhibition of MEK/ERK signalling pathway promotes erythroid differentiation and reduces HSCs engraftment in ex vivo expanded haematopoietic stem cells
por: Zarrabi, Morteza, et al.
Publicado: (2017)

ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors
por: Abbosh, Christopher, et al.
Publicado: (2021)

NIPT Technique Based on the Use of Long Chimeric DNA Reads
por: Belova, Vera, et al.
Publicado: (2020)

Role of ctDNA in Breast Cancer
por: Sant, Marta, et al.
Publicado: (2022)

The Role of ctDNA in Gastric Cancer
por: Mencel, Justin, et al.
Publicado: (2022)

Performance Evaluation of NIPT in Detection of Chromosomal Copy Number Variants Using Low-Coverage Whole-Genome Sequencing of Plasma DNA
por: Liu, Hongtai, et al.
Publicado: (2016)

Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples
por: Gumà, Josep, et al.
Publicado: (2022)

Pan-cancer analysis of microRNA expression profiles highlights microRNAs enriched in normal body cells as effective suppressors of multiple tumor types: A study based on TCGA database
por: Moradi, Sharif, et al.
Publicado: (2022)

Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA
por: Yaghoubi Naei, Vahid, et al.
Publicado: (2023)

Association of ctDNA detection and recurrence assessment in patients with neoadjuvant treatment
por: Zhou, Jiaxin, et al.
Publicado: (2023)

HNF4α is possibly the missing link between epithelial–mesenchymal transition and Warburg effect during hepatocarcinogenesis
por: Shokouhian, Bahare, et al.
Publicado: (2022)

The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA
por: Liu, Binliang, et al.
Publicado: (2022)

Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy
por: Khatami, Fatemeh, et al.
Publicado: (2018)

Low expression of Talin1 is associated with advanced pathological features in colorectal cancer patients
por: Vafaei, Somayeh, et al.
Publicado: (2020)

Initial Clinical Experience with NIPT for Rare Autosomal Aneuploidies and Large Copy Number Variations
por: Harasim, Thomas, et al.
Publicado: (2022)

Liquid Biopsy, ctDNA Diagnosis through NGS
por: Lin, Chen, et al.
Publicado: (2021)

ctDNA as a biomarker of progression in oesophageal adenocarcinoma
por: Bonazzi, V.F., et al.
Publicado: (2022)

State of the Art: ctDNA in Upper Gastrointestinal Malignancies
por: Labiano, Ibone, et al.
Publicado: (2023)

Nuclear overexpression of DNA damage-inducible transcript 4 (DDIT4) is associated with aggressive tumor behavior in patients with pancreatic tumors
por: Tajik, Fatemeh, et al.
Publicado: (2023)

Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2018)

ctDNA Detection Based on DNA Clutch Probes and Strand Exchange Mechanism
por: Chang, Huan, et al.
Publicado: (2018)

High expression of DNA damage-inducible transcript 4 (DDIT4) is associated with advanced pathological features in the patients with colorectal cancer
por: Fattahi, Fahimeh, et al.
Publicado: (2021)

Cell‐based noninvasive prenatal testing (cbNIPT) detects pathogenic copy number variations
por: Hatt, Lotte, et al.
Publicado: (2020)

Performances of NIPT for copy number variations at different sequencing depths using the semiconductor sequencing platform
por: Yang, Jiexia, et al.
Publicado: (2021)

Potential value of ctDNA monitoring in metastatic HR + /HER2 − breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial
por: Chiu, Joanne, et al.
Publicado: (2023)

Detection of ctDNA in the plasma of patients with papillary thyroid carcinoma
por: Li, Huiqiang, et al.
Publicado: (2019)

Current status of ctDNA in precision oncology for hepatocellular carcinoma
por: Li, Yan, et al.
Publicado: (2021)

The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma
por: Ding, Yubo, et al.
Publicado: (2022)

Current and Future Clinical Applications of ctDNA in Immuno-Oncology
por: Stadler, Julia-Christina, et al.
Publicado: (2022)

Regulatory implications of ctDNA in immuno-oncology for solid tumors
por: Vellanki, Paz J, et al.
Publicado: (2023)

CTC, ctDNA, and Exosome in Thyroid Cancers: A Review
por: Wang, Wenwen, et al.
Publicado: (2023)

Systematic evaluation of NIPT aneuploidy detection software tools with clinically validated NIPT samples
por: Paluoja, Priit, et al.
Publicado: (2021)

A dual biomarker detection platform for quantitating circulating tumor DNA (ctDNA)
por: Cai, Chunyan, et al.
Publicado: (2018)

Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer
por: Zhou, Yidong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6j502h4nks5hcmq6rs0b1hfrtv